Literature DB >> 21364105

46-year-old man with fatigue and brown urine.

Michael A Mao1, John R Hoyt, Mark A Nyman.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21364105      PMCID： PMC3046946          DOI： 10.4065/mcp.2010.0197

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  13 in total

Review 1.  Clinical practice. Thrombotic thrombocytopenic purpura.

Authors:  James N George
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

2.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

Review 3.  Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.

Authors:  Suresh G Shelat; Jihui Ai; X Long Zheng
Journal:  Semin Thromb Hemost       Date:  2005-12       Impact factor: 4.180

Review 4.  Acute myeloid leukaemia.

Authors:  Elihu Estey; Hartmut Döhner
Journal:  Lancet       Date:  2006-11-25       Impact factor: 79.321

Review 5.  Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.

Authors:  Mini Michael; Elizabeth J Elliott; Jonathan C Craig; Greta Ridley; Elisabeth M Hodson
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

Review 6.  Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

7.  Reversible hepatic dysfunction associated with rhabdomyolysis.

Authors:  M Akmal; S G Massry
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

8.  Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.

Authors:  Melody Benjamin; Deirdra R Terrell; Sara K Vesely; Gene W Voskuhl; Bruce J Dezube; Johanna A Kremer Hovinga; Bernhard Lämmle; James N George
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

9.  Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura.

Authors:  Andreja Marn Pernat; Jadranka Buturović-Ponikvar; Janko Kovac; Bojan Knap; Vladimir Premru; Miha Benedik; Janez Varl; Natasa Skofic; Jakob Gubensek; Bostjan Kersnic; Rafael Ponikvar
Journal:  Ther Apher Dial       Date:  2009-08       Impact factor: 1.762

Review 10.  Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura.

Authors:  Karen K Swisher; Deirdra R Terrell; Sara K Vesely; Johanna A Kremer Hovinga; Bernhard Lämmle; James N George
Journal:  Transfusion       Date:  2009-02-06       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.